Ostra Jewell
Responsable des Ressources Humaines chez VERONA PHARMA PLC
Profil
Ostra Jewell is currently working as the Senior Vice President-Human Resources at Verona Pharma Plc.
Prior to this, Ms. Jewell held the position of Senior Director-Human Resources at Dova Pharmaceuticals, Inc. from 2017 to 2019, and Vice President-Human Resources at Coleman Research, Inc. from 2013 to 2017.
Ms. Jewell also worked as Vice President-Human Resources at G1 Therapeutics, Inc. Ms. Jewell completed an MBA from George Mason University in 1997 and obtained an undergraduate degree from Indiana University in 1994.
Postes actifs de Ostra Jewell
| Sociétés | Poste | Début |
|---|---|---|
| VERONA PHARMA PLC | Responsable des Ressources Humaines | 01/09/2022 |
Anciens postes connus de Ostra Jewell
| Sociétés | Poste | Fin |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | 01/08/2019 |
| Coleman Research, Inc. | Responsable des Ressources Humaines | 01/11/2017 |
| G1 THERAPEUTICS, INC. | Responsable des Ressources Humaines | - |
Formation de Ostra Jewell
| Indiana University | Undergraduate Degree |
| George Mason University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
| Coleman Research, Inc. |
